Financial Perspectives’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91.4K | Buy |
722
+203
| +39% | +$25.7K | 0.03% | 234 |
|
|
2025
Q1 | $66.4K | Hold |
519
| – | – | 0.02% | 262 |
|
|
2024
Q4 | $68.6K | Hold |
519
| – | – | 0.02% | 266 |
|
|
2024
Q3 | $75.6K | Hold |
519
| – | – | 0.03% | 247 |
|
|
2024
Q2 | $71.2K | Hold |
519
| – | – | 0.03% | 235 |
|
|
2024
Q1 | $71.2K | Buy |
519
+98
| +23% | +$13.4K | 0.03% | 243 |
|
|
2023
Q4 | $57.2K | Buy |
421
+57
| +16% | +$7.74K | 0.02% | 258 |
|
|
2023
Q3 | $44.5K | Buy |
364
+31
| +9% | +$3.79K | 0.02% | 271 |
|
|
2023
Q2 | $42.3K | Buy |
333
+15
| +5% | +$1.9K | 0.02% | 278 |
|
|
2023
Q1 | $41.1K | Hold |
318
| – | – | 0.02% | 274 |
|
|
2022
Q4 | $41.8K | Hold |
318
| – | – | 0.02% | 270 |
|
|
2022
Q3 | $37.2K | Hold |
318
| – | – | 0.02% | 268 |
|
|
2022
Q2 | $37.4K | Hold |
318
| – | – | 0.02% | 266 |
|
|
2022
Q1 | $41.4K | Buy |
318
+68
| +27% | +$8.86K | 0.02% | 270 |
|
|
2021
Q4 | $38.2K | Hold |
250
| – | – | 0.02% | 272 |
|
|
2021
Q3 | $40.4K | Hold |
250
| – | – | 0.02% | 260 |
|
|
2021
Q2 | $40.9K | Sell |
250
-17,366
| -99% | -$2.84M | 0.02% | 280 |
|
|
2021
Q1 | $117K | Buy |
17,616
+17,602
| +125,729% | +$117K | 0.01% | 461 |
|
|
2020
Q4 | $2.12K | Buy |
+14
| New | +$2.12K | ﹤0.01% | 537 |
|